Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Lilly Partners with Area Health Systems to Help Enable Access to Important Antibody Infusion Therapies for COVID-19 Patients

Read more

Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA

Read more

Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients

Read more

Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma

Read more

Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine

Read more

Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial

Read more

Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment

Read more

Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate

Read more

Hoth Therapeutics Expands Research Collaboration Agreement with Weill Cornell Medicine to Continue the Advancement of HT-003 for Acne Treatment Research

Read more

Running for the 3rd year this March 2-4 to unite cross-industry experts from nephrology, cardiology, and endocrinology the 3rd CKD3 Summit is focusing on the question “what’s next?”

Read more

Posts pagination

Previous Page 1 of 957 … Page 434 of 957 … Page 957 of 957 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version